BIBLIOGRAFIA
(1) Global Cancer Facts & Figures 2nd Edition. American Cancer Society, 2010 (2) Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J
Clin 2005;55:74-108.
(3) Sundelof M, Ye W, Dickman PW, et al. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002;99:751–4.
(4) Xinopoulos D, Dimitroulopoulos D, TsamakidisK, et al. Palliative treatment of advanced esophageal cancer with metal-covered expandable stents: a cost-effectiveness and quality of life study. J BUON 2005;10:523–528.
(5) Altekruse SF, Kosary CL, Neyman N et al. :SEER Cancer Statistic review 1975-2007. Posted by SEER website, 2010
(6) Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681-1687,2001 (7) Baron TH: A practical guide for choosing an expandable metal stent for GI
malignancies: is a stent by any other name still a stent? Gastroint Endosc 54:269-272, 2001
(8) Petruzziello L, Costamagna G. Stenting inesophageal strictures. Dig Dis 2002;20:154–166.
(9) Bethge N, et al: Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J of
(10) Ring ME: How a dentist’s name became a synonym for a life-saving device: the story of Dr. Charles Stent. J Hist Dent 49:77-80, 2001
(11) Weldon CS, Ameli MM, Morovati SS, et al: A prosthetic stented homograft for mitral valve replacement. J Surg Res 12:548-552, 1966
(12) Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344:1681-1687,2001 (13) Ell C, May A: Self-expanding metal stents for palliation of stenosing
tumors of the distal esophagus and gastric cardia: a critical review.
Endoscopy 29:392-398, 1997
(14) Vakil N, Morris AI, Marcon N, et al: A prospective, random-ized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001;96:1791–6.
(15) May A, Hahn EG, Ell C: Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin
Gastroenterol 22:261-266, 1996
(16) Sabharwal T, Hamady MS, Chui S, et al: A randomized prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 52:922-926, 2003
(17) Parker CH, Peura DA. Palliative treatment of esophageal carcinoma using esophageal dilatation and prosthesis. Gastroenterol Clin North Am 20:717-29,
1991.
(18) Fugger R, Niederle B, Jantsch H, et al.: Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy 22:101-4, 1990 (19) Maroju NK, Anbalagan P, Kate V, Ananthakrishnan N. Improvement in
dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol 2006;25:62–65.
(20) Kozarek RA, Ball TJ, Brandabur JJ, et al. Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. Gastrointest Endosc 1996;43:204–208.
(21) Taal BG, Kooyman WM, Boot H. Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas: the experience of the Netherlands Cancer Institute. Eur J Gastroenterol Hepatol 1998;10:745–752.
(22) Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302–1307.
(23) Sanyika C, Corr P, Haffejee A. Palliative treatment of oesophageal carcinoma—efficacy of plastic versus self-expandable stents. S Afr Med 1999;89:640–643.
(24) Solito B, Repici A, Van Boeckel G.A. et al. New metal stent with a controlled-release system for pallation of malignant dysphagia: a prospective, multi center study. Gastrointest Endosc 2010, 3: 455-460.
recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004;36:880-6.
(26) Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia.
Am J Gastroenterol 2007;102:2667-77.
(27) Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet
2004;364:1497-504.
(28) Sabharwal T, Hamady MS, Chui S, et al. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003;52:922-6.
(29) Verschuur EM, Steyerberg EW, Kuipers EJ, et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 2007;65:592-601.
(30) Verschuur EM, Repici A, Kuipers EJ, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008;103:304-12.
(31) Conigliaro R, Battaglia G, Repici A, et al. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol 2007;19:195-203.
(32) Dormann AJ, Eisendrath P, Wigginghaus B, et al. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003;35:207-11.
(33) Szegedi L, Gal I, Kosa I, et al. Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J
Gastroenterol Hepatol 2006;18:1197-201.
(34) Verschuur EM, Homs MY, Steyerberg EW, et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 2006;63:134-40.
(35) O’Donnell CA, Fullarton GM, Watt E, et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002;89:985–92.
(36) Siersema PD, Hop WC, van Blankestein M, et al. A com- parison of 3 types of covered metal stents for the pallia- tion of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study.
Gastrointest Endosc 2001;54:145–53.
(37) Siersema PD, Hop WC, Dees J et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study.
Gastrointest Endosc 1998;47:113–20.
(38) Siersema P: Treatment options for esophageal strictures. Nat Clin Pract
Gastroenterol Hepatol 5:142-152, 2008
Gastrointest Endosc Clin N Am 17:83-104, 2007
(40) Dua KS, Kozarek R, Kim J, et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001;53:603-13
(41) Homs MY, Wahab PJ, Kuipers EJ, et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc 2004;60:695-702.
(42) Kocher M, Dlouhy M, Neoral C, et al. Esophageal stent with antireflux valve for tumors involving the cardia: work in progress. J Vasc Interv Radiol 1998;9:1007-10.
(43) Laasch HU, Marriott A, Wilbraham L, et al. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002;225:359-65.
(44) Osugi H, Lee S, Higashino M, et al. Usefulness of self-expandable metallic stent with an antireflux mechanism as a palliation for malignant strictures at the gastroesophageal junction. Surg Endosc 2002;16:1478-82.
(45) Power C, Byrne PJ, Lim K, et al. Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial. Dis Esophagus 2007;20:466-70.
(46) Sabharwal T, Gulati MS, Fotiadis N, et al. Randomised comparison of the FerX Ella antireflux stent and the Ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol
2008;23:723-8.
(47) choppmeyer K, Golsong J, Schiefke I, et al. Antireflux stents for palliation of malignant esophagocardial stenosis. Dis Esophagus 2007;20:89-93.
(48) Verschuur EM, Homs MY, Steyerberg EW, et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest Endosc 2006;63:134-40.